Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
Journal of the National Cancer Institute
|
March 20, 2019
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer
Rim S Kim, Nan Song, Patrick G Gavin, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma
Nilgun Tasdemir, Laura Savariau, Julie Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2020
Neratinib-Plus-Cetuximab in Quadruple-WT (<i>KRAS, NRAS, BRAF, PIK3CA</i>) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study
Samuel A Jacobs, James J Lee, Thomas J George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
Peilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2019
Genetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer
Kathryn L Penney, Barbara L Banbury, Stephanie Bien, et al.
JAMA Oncology
|
July 1, 2021
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial
Osama E Rahma, Greg Yothers, Theodore S Hong, et al.
Breast Cancer Research : BCR
|
December 5, 2019
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2<sup>+</sup> breast cancer
Samuel A Jacobs, André Robidoux, Jame Abraham, et al.
Breast Cancer Research : BCR
|
January 24, 2020
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
Samuel A Jacobs, André Robidoux, Jame Abraham, et al.
Mayo Clinic Proceedings
|
February 13, 2026
Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency)
Michael McCarthy, Antonina A Wojcik, Emily G Barr Fritcher, et al.
JAMA Surgery
|
May 7, 2025
Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial
Mark Basik, Reena S Cecchini, Jennifer F De Los Santos, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
Journal of the National Cancer Institute
|
March 20, 2019
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer
Rim S Kim, Nan Song, Patrick G Gavin, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma
Nilgun Tasdemir, Laura Savariau, Julie Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2020
Neratinib-Plus-Cetuximab in Quadruple-WT (<i>KRAS, NRAS, BRAF, PIK3CA</i>) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study
Samuel A Jacobs, James J Lee, Thomas J George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
Peilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2019
Genetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer
Kathryn L Penney, Barbara L Banbury, Stephanie Bien, et al.
JAMA Oncology
|
July 1, 2021
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial
Osama E Rahma, Greg Yothers, Theodore S Hong, et al.
Breast Cancer Research : BCR
|
December 5, 2019
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2<sup>+</sup> breast cancer
Samuel A Jacobs, André Robidoux, Jame Abraham, et al.
Breast Cancer Research : BCR
|
January 24, 2020
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
Samuel A Jacobs, André Robidoux, Jame Abraham, et al.
Mayo Clinic Proceedings
|
February 13, 2026
Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency)
Michael McCarthy, Antonina A Wojcik, Emily G Barr Fritcher, et al.
JAMA Surgery
|
May 7, 2025
Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial
Mark Basik, Reena S Cecchini, Jennifer F De Los Santos, et al.
Page
of 12